Analysis of clinical factors for hyperoxaluria in patients with calcium oxalate stones: a single-center retrospective cross-sectional study
- 1Department of Urology, The First Affiliated Hospital of Guangzhou Medical University
Abstract
Background Hyperoxaluria is associated with calcium oxalate (CaOx) stone disease and is assessed by quantitative urinary oxalate excretion. We aimed to identify routinely available clinical factors associated with concurrent study-defined hyperoxaluria among adults with CaOx stones. Methods This single-center retrospective cross-sectional study included 385 adults with infrared-spectroscopy-confirmed CaOx stones who underwent stone surgery and completed at least one valid preoperative 24-hour urine collection 3–10 days before surgery between January 1 and December 1, 2024. Study-defined hyperoxaluria was urinary oxalate excretion ≥ 40 mg/24 h. The primary exploratory model used forward likelihood-ratio selection after univariable screening; a sensitivity model simultaneously included age, sex, body mass index, and the four factors retained by the stepwise model. Results Hyperoxaluria was present in 132 of 385 patients (34.3%). In the primary stepwise model, hyperlipidemia (odds ratio [OR] 1.591, 95% confidence interval [CI] 1.031–2.457; P = 0.036), a positive urine nitrite test (OR 2.356, 95% CI 1.114–4.986; P = 0.025), diabetes mellitus (OR 1.811, 95% CI 1.055–3.109; P = 0.031), and at least two previous stone operations (OR 1.632, 95% CI 1.048–2.541; P = 0.030) were associated with hyperoxaluria. In the prespecified sensitivity model, all effect directions were unchanged, but hyperlipidemia was not statistically significant (OR 1.499, 95% CI 0.966–2.326; P = 0.071); the other three associations remained statistically significant. Conclusions In surgically treated adults with composition-confirmed CaOx stones, the stepwise model identified four concurrent correlates of study-defined hyperoxaluria, whereas sensitivity analysis indicated that the hyperlipidemia association was model-dependent. The associations with a positive urine nitrite test, diabetes mellitus, and at least two previous stone operations were more stable across models. These exploratory indicators may help prioritize confirmatory 24-hour urine testing where access is limited, but they cannot replace metabolic evaluation or establish causality.
Related
- Epidemiology, Clinical Profiles, Antimicrobial Resistance, and Inflammatory Risk Factors of Aeromonas Infections in Hospitalized Patients: A Retrospective Cohort Study from a Hospital in Zhoushan Archipelago, China
- Factors associated with probable sarcopenic dysphagia and development of a clinical classification model in older ICU patients: a cross-sectional study.
- Clinical features of COVID-19 patients hospitalized at the Tashkent State Medical University and risk factors for intensive care unit admission: a cross-sectional study from Uzbekistan, Central Asia
- Clinical spectrum and risk factors for severe arrhythmias in non-surgical pediatric patients: a single-center retrospective study.
- Treatment Adherence and its Association with Demographic Characteristics and Clinical Factors Among Patients with Hypertension: A Cross-Sectional, Descriptive-Correlational Study.
BibTeX
@article{huang2026analysis,
title = {{Analysis of clinical factors for hyperoxaluria in patients with calcium oxalate stones: a single-center retrospective cross-sectional study}},
author = {Yingpan Huang and Lili Ou and Fuyang Lin and Jiapeng Liu and Yang Liu and Junhao Zheng and Yongda Liu},
journal = {BMC Urology},
year = {2026},
month = sep,
doi = {10.1186/s12894-026-02344-6},
url = {https://doi.org/10.1186/s12894-026-02344-6},
note = {CC BY},
}
RIS
TY - JOUR
TI - Analysis of clinical factors for hyperoxaluria in patients with calcium oxalate stones: a single-center retrospective cross-sectional study
AU - Yingpan Huang
AU - Lili Ou
AU - Fuyang Lin
AU - Jiapeng Liu
AU - Yang Liu
AU - Junhao Zheng
AU - Yongda Liu
PY - 2026
DA - 2026/09/01
JO - BMC Urology
DO - 10.1186/s12894-026-02344-6
UR - https://doi.org/10.1186/s12894-026-02344-6
AB - Background Hyperoxaluria is associated with calcium oxalate (CaOx) stone disease and is assessed by quantitative urinary oxalate excretion. We aimed to identify routinely available clinical factors associated with concurrent study-defined hyperoxaluria among adults with CaOx stones. Methods This single-center retrospective cross-sectional study included 385 adults with infrared-spectroscopy-confirmed CaOx stones who underwent stone surgery and completed at least one valid preoperative 24-hour urine collection 3–10 days before surgery between January 1 and December 1, 2024. Study-defined hyperoxaluria was urinary oxalate excretion ≥ 40 mg/24 h. The primary exploratory model used forward likelihood-ratio selection after univariable screening; a sensitivity model simultaneously included age, sex, body mass index, and the four factors retained by the stepwise model. Results Hyperoxaluria was present in 132 of 385 patients (34.3%). In the primary stepwise model, hyperlipidemia (odds ratio [OR] 1.591, 95% confidence interval [CI] 1.031–2.457; P = 0.036), a positive urine nitrite test (OR 2.356, 95% CI 1.114–4.986; P = 0.025), diabetes mellitus (OR 1.811, 95% CI 1.055–3.109; P = 0.031), and at least two previous stone operations (OR 1.632, 95% CI 1.048–2.541; P = 0.030) were associated with hyperoxaluria. In the prespecified sensitivity model, all effect directions were unchanged, but hyperlipidemia was not statistically significant (OR 1.499, 95% CI 0.966–2.326; P = 0.071); the other three associations remained statistically significant. Conclusions In surgically treated adults with composition-confirmed CaOx stones, the stepwise model identified four concurrent correlates of study-defined hyperoxaluria, whereas sensitivity analysis indicated that the hyperlipidemia association was model-dependent. The associations with a positive urine nitrite test, diabetes mellitus, and at least two previous stone operations were more stable across models. These exploratory indicators may help prioritize confirmatory 24-hour urine testing where access is limited, but they cannot replace metabolic evaluation or establish causality.
SN - 1471-2490
ER -